Skip to playerSkip to main content
  • 4 months ago
Trump’s Most-Favored-Nation pricing deal with Pfizer ignited the biggest two-day health care rally in five years. The agreement aligns Medicaid drug costs with the lowest prices in developed nations and includes discounts up to 80%, $70 billion in U.S. investments, and revenue repatriation. The White House is pressuring other drugmakers to strike similar deals under the threat of tariffs.

Category

🗞
News
Transcript
00:00It's Benzinga bringing Wall Street to Main Street.
00:02Investors cheered a breakthrough pricing agreement between President Donald Trump
00:06and Pfizer that sparked the biggest two-day healthcare rally in five years, according to
00:12Benzinga. The healthcare select sector SBDR fund jumped over 5% on Tuesday and Wednesday,
00:19its strongest run since November 2020. The White House announced a most favored nation
00:24pricing deal with Pfizer, aligning Medicaid drug costs in the U.S. with the lowest paid
00:29by other developed nations. Pfizer will provide most favored nation pricing to all U.S. state
00:35Medicaid programs, guaranteeing states pay no more than the lowest prices in other developed
00:40nations. The pharmaceutical giant will offer direct-to-patient discounts of up to 80% on
00:46select drugs, repatriate foreign revenue, and invest $70 billion in U.S. pharmaceutical
00:52manufacturing. For all things money, visit Benzinga.com.
Comments

Recommended